A new selective antagonist of the nociceptin receptor

No abstract is available for this paper.

• Publication year

  1998

• Venue

  British Journal of Pharmacology

• Publication date

  1998-01-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1038/sj.bjp.0701640PMID 9489602PMCID PMC1565170
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synthesis and pharmacological activity of the N-terminal dermorphin tetrapeptide analogs with CH2-NH peptide bond isosteres.

  2009cited by this paper
• Address and message sequences for the nociceptin receptor: a structure-activity study of nociceptin-(1-13)-peptide amide.

  1997cited by this paper
• Pharmacological characterization of nociceptin receptor: an in vitro study.

  1997cited by this paper
• Effects of σ ligands on the nociceptin/orphanin FQ receptor co‐expressed with the G‐protein‐activated K+ channel in Xenopus oocytes

  1997cited by this paper
• THE ACTION OF MORPHINE AND RELATED SUBSTANCES ON CONTRACTION AND ON ACETYLCHOLINE OUTPUT OF COAXIALLY STIMULATED GUINEA‐PIG ILEUM

  1997cited by this paper
• Nociceptin/Orphanin FQ Metabolism: Role of Aminopeptidase and Endopeptidase 24.15

  1997cited by this paper
• The mouse vas deferens: a pharmacological preparation sensitive to nociceptin.

  1996cited by this paper
• Orphanin FQ: A Neuropeptide That Activates an Opioidlike G Protein-Coupled Receptor

  1995cited by this paper
• Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor

  1995cited by this paper
• EFFECT OF MORPHINE ON ADRENERGIC TRANSMISSION IN THE MOUSE VAS DEFERENS. ASSESSMENT OF AGONIST AND ANTAGONIST POTENCIES OF NARCOTIC ANALGESICS

  1975cited by this paper

• Opioid receptors in GtoPdb v.2025.1

  2025cites this paper
• A Multi-Angle Approach to Predict Peptide-GPCR Complexes: The N/OFQ-NOP System as a Successful AlphaFold Application Case Study

  2024cites this paper
• Opioid receptors in GtoPdb v.2023.1 Opioid receptors in GtoPdb v.2023.1

  2023cites this paper
• Spotlight on Nociceptin/Orphanin FQ Receptor in the Treatment of Pain

  2022cites this paper
• Comprehensive overview of biased pharmacology at the opioid receptors: biased ligands and bias factors.

  2021cites this paper
• Effects of non-peptide nociceptin/orphanin FQ receptor ligands on methylphenidate-induced hyperactivity in mice: Implications for bipolar disorders.

  2020cites this paper
• Managing Parkinson's disease: moving ON with NOP

  2020cites this paper
• NOP-Related Mechanisms in Pain and Analgesia.

  2019cites this paper
• Targeting opioid dysregulation in depression for the development of novel therapeutics.

  2019cites this paper
• Nociceptin/orphanin FQ modulates energy homeostasis through inhibition of neurotransmission at VMN SF-1/ARC POMC synapses in a sex- and diet-dependent manner

  2019cites this paper
• Pharmacological Assays for Investigating the NOP Receptor.

  2019cites this paper
• Opioid receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

  2019cites this paper
• Nociceptin/Orphanin FQ (N/OFQ) conjugated to ATTO594: a novel fluorescent probe for the N/OFQ (NOP) receptor

  2018cites this paper
• NOP receptor pharmacological profile – A dynamic mass redistribution study

  2018cites this paper
• Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems

  2016influential citation
• Efeitos in vivo e in vitro de agonistas parciais do receptor NOP: implicações para o tratamento da ansiedade, depressão e mania

  2016cites this paper
• Central Analgesic Activity

  2016cites this paper
• Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic-versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligands.

  2016cites this paper
• Helix-constrained nociceptin peptides are potent agonists and antagonists of ORL-1 and nociception.

  2015cites this paper
• Structure activity studies of nociceptin/orphanin FQ(1-13)-NH2 derivatives modified in position 5.

  2015cites this paper
• Pharmacological Profile of Nociceptin/Orphanin FQ Receptors Interacting with G-Proteins and β-Arrestins 2

  2015cites this paper
• BU08073 a buprenorphine analogue with partial agonist activity at μ‐receptors in vitro but long‐lasting opioid antagonist activity in vivo in mice

  2015cites this paper
• Synthesis and biological activity of small peptides as NOP and opioid receptors' ligands: view on current developments.

  2015cites this paper
• Utilização da escala multidimensional composta para avaliação de dor aguda pós-cirúrgica em gato para comparação de eficácia de três protocolos analgésicos no modelo cirúrgico de ovariohisterectomia eletiva felina

  2014cites this paper
• The Nociceptin System in Inflammation and Sepsis

  2013cites this paper
• A Review of the NOP (ORL-1)-Nociceptin/Orphanin FQ System Covering Receptor Structure, Distribution, Role in Analgesia and Reward and Interactions with Other Receptors

  2013cites this paper
• Nociceptin/orphanin FQ receptor antagonists as innovative antidepressant drugs.

  2013cites this paper
• Medicinal Chemistry, Pharmacology, and Biological Actions of Peptide Ligands Selective for the Nociceptin/Orphanin FQ Receptor

  2013cites this paper
• A single compound alternative to a buprenorphine/naltrexone combination

  2012cites this paper
• Synthesis and biological activity of new series of N-modified analogues of the N/OFQ(1–13)NH2 with aminophosphonate moiety

  2011cites this paper
• Nociceptin/orphanin FQ - NOP receptor system: novel genetic and pharmacological tools

  2011cites this paper
• The role of nociceptin and dynorphin in chronic pain: implications of neuro-glial interaction.

  2011cites this paper
• UFP‐112 a Potent and Long‐Lasting Agonist Selective for the Nociceptin/Orphanin FQ Receptor

  2011cites this paper
• Nociceptin/orphanin phenylalanine glutamine (FQ) receptor and cardiovascular disease.

  2011cites this paper
• Synthesis, biological evaluation and structural characterization of novel glycopeptide analogues of nociceptin N/OFQ.

  2011cites this paper
• Recently patented and promising ORL-1 ligands: where have we been and where are we going?

  2010cites this paper
• Comparative biochemical and pharmacological characterization of a novel, NOP receptor selective hexapeptide, Ac-RYYRIR-ol.

  2010cites this paper
• Modulation of nociceptin receptor and nociceptin/orphanin FQ mRNA expression in whole blood cultures

  2010cites this paper
• Neurobiology, pharmacology, and medicinal chemistry of neuropeptide S and its receptor

  2010cites this paper
• Nociceptin/orphanin FQ receptor ligands : pharmacological studies

  2009cites this paper
• Synthesis of amide-type fluoroalkene dipeptide isosteres by an intramolecular redox reaction.

  2009cites this paper
• Biochemical and pharmacological characterizations of the novel endogenous opioid peptide motifs and synthetic nociceptin hexapeptide sequences

  2009cites this paper
• Pharmacological profile of NOP receptors coupled with calcium signaling via the chimeric protein Gαqi5

  2009cites this paper
• Nociceptin-Orphanin FQ Peptide Receptor

  2008cites this paper
• Presynaptic neuropeptide receptors.

  2008cites this paper
• Tryptophan replacement in the nociceptin/orphanin FQ receptor ligand Ac-RYYRWK-NH2.

  2008cites this paper
• Role of nociceptin/orphanin FQ and the pseudopeptide [Phe1Psi(CH2NH)Gly2]-nociceptin(1-13)-NH2 and their interaction with classic opioids in the modulation of thermonociception in the land snail Helix aspersa.

  2008cites this paper
• Nociceptin/orphanin FQ peptide receptor as a therapeutic target for obesity.

  2008cites this paper
• Designed modification of partial agonist of ORL1 nociceptin receptor for conversion into highly potent antagonist.

  2008cites this paper
• Activities of mixed NOP and μ‐opioid receptor ligands

  2008cites this paper
• The nociceptin/orphanin FQ receptor: a target with broad therapeutic potential

  2008cites this paper
• [Phe 1 psi(CH 2 -NH)-Gly 2 ]Nociceptin-(1-13)-NH 2

  2008cites this paper
• The ORL-1 receptor system: are there opportunities for antagonists in pain therapy?

  2008cites this paper
• Cardiovascular and renal effects of nociceptin/orphanin FQ: a new mediator to target?

  2007cites this paper
• Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with Cα,α-dialkylated amino acids

  2007cites this paper
• Nociceptin/orphanin FQ peptide receptors: pharmacology and clinical implications.

  2007cites this paper
• In vitro pharmacological characterisation of a novel cyclic nociceptin/orphanin FQ analogue c[Cys7,10]N/OFQ(1–13)NH2

  2007cites this paper
• Anti-nociceptive and anti-allodynic effects of a high affinity NOP hexapeptide [Ac-RY(3-Cl)YRWR-NH2] (Syn 1020) in rodents.

  2007cites this paper
• Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with Calpha,alpha-dialkylated amino acids.

  2007cites this paper
• [Phe 1psi(CH2-NH)-Gly2]Nociceptin-(1-13)-NH2

  2007cites this paper
• Agonist-regulated internalization and desensitization of the human nociceptin receptor expressed in CHO cells.

  2007cites this paper
• Effects of ORL1 Receptor Agonists and Antagonists in Nociception: A Review

  2006cites this paper
• Effects of [Nphe1]nociceptin(1-13)NH2, [Phe1(CH2-NH)Gly2]nociceptin(1- 13)NH2, and nocistatin on nociceptin inhibited constrictions of guinea pig isolated bronchus.

  2006cites this paper
• UFP-101, a peptide antagonist selective for the nociceptin/orphanin FQ receptor.

  2006cites this paper
• Orphanin FQ/nociceptin is a physiological regulator of prolactin secretion in female rats.

  2006cites this paper
• Biochemical, functional and pharmacological characterization of novel hexapeptide ligands targeting nociceptin/orphanin FQ receptor, in vitro and in vivo studies

  2006cites this paper
• In vitro and in vivo pharmacological characterization of the nociceptin/orphanin FQ receptor ligand Ac-RYYRIK-ol.

  2006cites this paper
• N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands.

  2005cites this paper
• Functional Selectivity of Nociceptin/Orphanin FQ Peptide Receptor Partial Agonists on Cardiovascular and Renal Function

  2005cites this paper
• Pharmacological characterisation of recombinant nociceptin receptors

  2005cites this paper
• UFP-101, a Peptide Antagonist Selective for the Nociceptin (cid:1) Orphanin FQ Receptor

  2005cites this paper
• [(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a Highly Potent and Selective Agonist of the Nociceptin/Orphanin FQ Receptor

  2005influential citation
• Lack of involvement of dopamine and serotonin during the orphanin FQ/Nociceptin (OFQ/N)-induced prolactin secretory response.

  2005cites this paper
• Spinal and local peripheral antiallodynic activity of Ro64‐6198 in neuropathic pain in the rat

  2005cites this paper
• NOC/oFQ activates ERK and JNK but not p38 MAPK to impair prostaglandin cerebrovasodilation after brain injury.

  2005cites this paper
• Structure-activity studies on high affinity NOP-active hexapeptides.

  2004cites this paper
• Biostable aptamers with antagonistic properties to the neuropeptide nociceptin/orphanin FQ.

  2004cites this paper
• Functional coupling of the nociceptin/orphanin FQ receptor in dog brain membranes.

  2004cites this paper
• Pharmacological profile of nociceptin/orphanin FQ receptors regulating 5‐hydroxytryptamine release in the mouse neocortex

  2004cites this paper
• Nociceptin/orphanin FQ modulates spatial learning via ORL-1 receptors in the dorsal hippocampus of the rat.

  2004cites this paper
• Nociceptin antagonism: probing the receptor by N-acetyl oligopeptides.

  2004cites this paper
• Pharmacological Characterization of Nociceptin/Orphanin FQ Receptors, a Novel Opioid Receptor Family, in the Midbrain Periaqueductal Gray

  2004cites this paper
• Study in vitro and in vivo of nociceptin/orphanin FQ(1-13)NH2 analogues substituting N-Me-Gly for Gly2 or Gly3.

  2004cites this paper
• Roles of nociceptin/orphanin FQ and nociceptin/orphanin FQ peptide receptor in respiratory rhythm generation in the medulla oblongata: an in vitro study.

  2003cites this paper
• Problems of Drug Dependence, 2002: Proceedings of the 64th Annual Scientific Meeting, The College on Problems of Drug Dependence, Inc.

  2003cites this paper
• Sodium ions and GTP decrease the potency of [Nphe1]N/OFQ(1-13)NH2 in blocking nociceptin/orphanin FQ receptors coupled to cyclic AMP in N1E-115 neuroblastoma cells and rat olfactory bulb.

  2003cites this paper
• Cardiovascular responses to microinjections of nociceptin into a midline area in the commissural subnucleus of the nucleus tractus solitarius of the rat.

  2003cites this paper
• Utilizing Functional Genomics to Identify New Pain Treatments

  2003cites this paper
• Pharmacological profiles of presynaptic nociceptin/orphanin FQ receptors modulating 5‐hydroxytryptamine and noradrenaline release in the rat neocortex

  2003cites this paper
• Assessment of the activity of a novel nociceptin/orphanin FQ analogue at recombinant human nociceptin/orphanin FQ receptors expressed in Chinese hamster ovary cells.

  2003cites this paper
• Nociceptin inhibition of acetylcholine efflux from different brain areas

  2003cites this paper
• N-terminal modifications leading to peptide ORL1 partial agonists and antagonists.

  2003cites this paper
• Involvement of sympathetic efferents but not capsaicin-sensitive afferents in nociceptin-mediated dual control of rat synovial blood flow.

  2003cites this paper
• Partial agonist behaviour depends upon the level of nociceptin/orphanin FQ receptor expression: studies using the ecdysone‐inducible mammalian expression system

  2003cites this paper
• Nociceptin/Orphanin FQ(1-13)NH2 analogues modified in the Phe1-Gly2 peptide bond.

  2003cites this paper
• Peptide and nonpeptide ligands for the nociceptin/orphanin FQ receptor ORL1: research tools and potential therapeutic agents.

  2003cites this paper
• Pharmacological characterisation of [(pX)Phe4]nociceptin(1-13)NH2 analogues

  2002cites this paper
• Pharmacological properties of nociceptin/orphanin FQ‐induced stimulation and inhibition of cyclic AMP formation in distinct layers of rat olfactory bulb

  2002cites this paper
• Synthesis and pharmacological activity of a new antagonist of the OP4 receptor

  2002cites this paper
• Gastric acid secretion stimulated by centrally injected nociceptin in urethane-anesthetized rats.

  2002cites this paper